Hillstream BioPharma (HILS) News Today → The Next Nvidia? (From InvestorPlace) (Ad) Free HILS Stock Alerts $0.37 -0.01 (-2.62%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHill & Smith PLC HILSmorningstar.com - April 17 at 7:23 PMKiromic BioPharma Inc Ordinary Shares KRBPmorningstar.com - October 31 at 6:02 PMHillstream BioPharma Progressing Towards Acquiring Clinical Stage Asset and Announces Corporate Name Change to Tharimmune, Inc.finance.yahoo.com - September 22 at 12:10 PMDawson James Securities Announces October Date for 8th Annual Small Cap Growth Conferencefinance.yahoo.com - September 21 at 9:45 AMHillstream Enters into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic Pruritisfinance.yahoo.com - September 11 at 4:50 PMHillstream BioPharma to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13finance.yahoo.com - September 8 at 6:19 PMHillstream – Drug Maker Licenses Critical New Technology In Fight Against Cancerbenzinga.com - August 30 at 6:07 PMNMTRQ 9 Meters Biopharma, Inc.seekingalpha.com - August 25 at 10:22 AMHillstream BioPharma to Present at the Sidoti Micro-Cap Virtual Conference on August 16-17, 2023finance.yahoo.com - August 9 at 9:10 AMHillstream Advances Next-Gen Multispecific Antibodies for Solid Tumors with Lead HER2/HER3 Program, HSB-3215finance.yahoo.com - July 20 at 9:23 AMHillstream BioPharma Announces Strategic Reprioritization of Pipeline to Targeting HER2/HER3 Solid Tumors via Bispecific and ADC Antibodies and Biologicsfinance.yahoo.com - July 10 at 1:07 PMHillstream BioPharma Licenses Technology to Develop Proprietary HER2 and HER3 Antibody Drug Conjugates against Drug-Resistant Breast, Lung, Gastric, and Ovarian Cancersfinance.yahoo.com - July 6 at 10:42 AMHILS - Hillstream BioPharma, Inc.finance.yahoo.com - June 9 at 8:05 PMHillstream BioPharma Strengthens its Board of Directors with Appointment of Kelly Andersonfinance.yahoo.com - May 15 at 10:45 AMHillstream BioPharma, Inc.: Hillstream BioPharma Announces Closing of Public Offering of Common Stockfinanznachrichten.de - May 4 at 1:01 AMHillstream BioPharma Announces Closing of Public Offering of Common Stockfinance.yahoo.com - May 2 at 5:56 PMHillstream BioPharma to Present at Upcoming May 2023 Investor and Industry Conferencesfinance.yahoo.com - May 2 at 12:55 PMHillstream BioPharma Stock (NASDAQ:HILS), Short Interest Reportbenzinga.com - April 29 at 1:39 PMHillstream BioPharma, Inc.: Hillstream BioPharma Announces Proposed Public Offeringfinanznachrichten.de - April 28 at 6:18 PMHillstream BioPharma Shares Slide Premarket on Stock Offering >HILSmarketwatch.com - April 28 at 1:02 PMWhy Is Hillstream BioPharma (HILS) Stock Down 57% Today?investorplace.com - April 28 at 9:22 AMHillstream BioPharma, Inc.: Hillstream BioPharma Announces Pricing of Public Offeringfinanznachrichten.de - April 28 at 7:41 AMHillstream BioPharma Announces Pricing of Public Offeringfinance.yahoo.com - April 27 at 11:45 PMHillstream BioPharma Announces Proposed Public Offeringfinance.yahoo.com - April 27 at 6:44 PMHillstream BioPharma Selects OncoBay Clinical to Advance Clinicaltmcnet.com - April 13 at 2:08 PMHillstream BioPharma Selects OncoBay Clinical to Advance Clinical and Regulatory Development for its Lead Drug Candidate HSB-1216, an Anti-Cancer Mechanismfinance.yahoo.com - April 13 at 9:07 AMHillstream BioPharma’s Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Growfinance.yahoo.com - April 12 at 1:06 PMHillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Growbenzinga.com - April 11 at 11:00 AMHillstream BioPharma Announces Pharmacokinetic Data of HSB-1216 Supportive of its Development Strategy and Pre-clinical Datafinance.yahoo.com - April 10 at 1:21 PMHillstream BioPharma to Participate in Two Major Industry Conferences in April 2023finance.yahoo.com - March 28 at 10:38 AMHillstream BioPharma to Attend the 35th Annual ROTH Conference on March 12-14, 2023finance.yahoo.com - February 28 at 8:02 PMHillstream BioPharma Regains Compliance with Nasdaq Listing Minimum Bid Price Rulefinance.yahoo.com - February 15 at 8:56 AMHillstream BioPharma Provides Webcast for its R&D Day on February 14th, 2023 at 10:00am ETfinance.yahoo.com - February 13 at 8:25 PMHillstream BioPharma Signs Exclusive Option Agreement with Applied Biomedical Science Institute (ABSI) to License Technology for HER2 and HER3 to be Developed for Potential Treatments Against Drug Resistant Cancers Including HER2-Positive Metastatic Breast Cancer, Gastric Cancer, Lung Cancer and Ovarian Cancerfinance.yahoo.com - February 13 at 10:24 AMHillstream Nearly Doubles on Test Resultsbaystreet.ca - February 10 at 12:41 PMHillstream Soars on Promising HSB-1216 Data in Lung Cancermsn.com - February 10 at 12:41 PMIn a KRAS G12C-mutated NSCLC cell line, Calu-1, Hillstream BioPharma Demonstrated Significantly Greater Tumor Inhibition Combining Pembrolizumab, an anti-PD-1 antibody, and HSB-1216, a Ferroptosis Inducerfinance.yahoo.com - February 10 at 7:34 AMHillstream BioPharma Announces Acceptance of Abstract at AACR 2023 Annual Meeting Highlighting HSB-510 as Novel Bi-functional Inhibitor for Solid Tumors & Leukemiasfinance.yahoo.com - February 8 at 8:42 AMHillstream BioPharma to Host Virtual R&D Day to Showcase its Emerging Immuno-oncology Pipeline Targeting Drug-Resistant Cancersfinance.yahoo.com - February 6 at 9:46 AMWhy Are Hillstream BioPharma Shares Trading Over 100% Today?finance.yahoo.com - January 31 at 2:47 PMHillstream BioPharma Signs an Exclusive Option Agreement to Advance Next-Generation Anti-MUC1-C Agents for Drug Resistant Cancersfinance.yahoo.com - January 31 at 9:46 AMmarketbeat.com - January 31 at 9:37 AMHillstream BioPharma to Present at the Virtual Sidoti Micro-Cap Conference on January 18-19, 2023finance.yahoo.com - January 17 at 4:04 PMInsiders who purchased Hillstream BioPharma, Inc. (NASDAQ:HILS) stock last year recover some losses which currently stand at US$86kfinance.yahoo.com - December 12 at 7:20 AMmarketbeat.com - December 9 at 10:49 AMHillstream BioPharma Announces Development of Proprietary Targeted Biologics, Knob Quatrabodies™ (HSB-1940) against PD-1, by combining Quatramers™ with OmniAb’s Picobodies™, via a Collaboration Agreement, against Novel, Unreachable and Undruggable Epitopes in High Value Validated Targetsfinance.yahoo.com - December 1 at 9:17 AMHillstream’s New Anti-Cancer Mechanism Quatramer-based Ferroptosis Inducer, HSB-1216 Abstract Available for Viewing at EORTC-NCI-AACR Symposiumfinance.yahoo.com - October 18 at 6:14 PMHillstream BioPharma, Inc. to Present at Upcoming Investor Conferencesfinance.yahoo.com - October 6 at 11:03 AMHillstream BioPharma, Inc. (HILS)finance.yahoo.com - September 21 at 10:10 PMHillstream BioPharma to Participate in the Fierce...benzinga.com - September 16 at 10:59 AM Get Hillstream BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HILS and its competitors with MarketBeat's FREE daily newsletter. Email Address World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. HILS Media Mentions By Week HILS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HILS News Sentiment▼0.000.43▲Average Medical News Sentiment HILS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HILS Articles This Week▼00▲HILS Articles Average Week Get Hillstream BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HILS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADXS News Today SHPH News Today ENVB News Today AIMD News Today CVKD News Today SBFM News Today XBIO News Today UPC News Today FWBI News Today PTIX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HILS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyWill this $2 AI stock double overnight?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hillstream BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
